Table 1.
Baseline characteristics [mean (SD) or number (%)], n=4182
| Characteristic | Mean (SD) |
|---|---|
| Age, years, mean (SD) | 72.9 (5.8) |
|
| |
| Total cholesterol, mg/dl, mean (SD) | 205.6 (36.4) |
|
| |
| HDL-C, mg/dl, mean (SD) | 44.5 (15.8) |
| HDL-C<40 mg/dL, no. (%) | 1815 (43.4) |
| HDL-C≥40 mg/dL, no. (%) | 2378 (56.6) |
|
| |
| Non-HDL-C, mg/dl, mean (SD) | 161.1 (36.2) |
| Non-HDL-C <100 mg/dl, no. (%) | 130 (3.1) |
| Non-HDL-C 100-<130 mg/dl, no. (%) | 691(16.5) |
| Non-HDL-C ≥130 mg/dl, no. (%) | 3361(80.3) |
|
| |
| Systolic blood pressure (SBP), mm Hg, mean (SD) | 131.3 (12.9) |
| SBP <140 mm Hg | 2894(69.2) |
| SBP ≥140 mm Hg | 1288(30.8) |
|
| |
| Diastolic blood pressure (DBP), mm Hg, mean(SD) | 78.2 (7.4) |
| DBP <90 mm Hg | 3847 (92.0) |
| DBP ≥90 mm Hg | 335 (8.0) |
|
| |
| Body mass index | 25.3(3.4) |
|
| |
| Current smoking, no.(%) | 145 (3.5) |
|
| |
| Regular physical activity, no. (%)* | 673 (16.2) |
|
| |
| Lipid-lowering drug use, no. (%) | 589 (14.0) |
|
| |
| Antihypertensive drug use (%) | 1254(30.0) |
|
| |
| Aspirin use (%) | 2046 (48.9) |
|
| |
| Serious comorbidities | |
| 0 | 1497(35.8) |
| 1 | 1952(46.7) |
| ≥2 | 733(17.5) |
|
| |
| Glomerular filtration rate <30 mg/dl (%) | 183 (4.4) |
HDL-C = High-density lipoprotein cholesterol
*
Defined as exercising to sweat ≥5 time per week, missing in 31 participants
**
Serious comorbidities included baseline chronic obstructive pulmonary disease, congestive heart failure, history of gastrointestinal bleeding, liver disease, renal disease, non-fatal cancer or cerebrovascular disease, excluding stroke but including transient ischemic attack or carotid artery surgery.